Cochlear Limited - Oticon Medical

Acquirer(s)

  • Cochlear Limited

Target(s)

  • Oticon Medical A/S

Summary

Cochlear Limited (Cochlear) proposes to acquire the shares and certain assets of Oticon Medical A/S (Oticon Medical) from Demant A/S.

In Australia, Cochlear and Oticon Medical both supply hearing solutions, specifically cochlear implants and bone conduction solutions.

Market inquiries

Submissions are invited from interested parties regarding Cochlear’s proposed acquisition of Oticon Medical.

Submissions should be forwarded electronically (preferably in PDF format) to mergers@accc.gov.au with the title “Submission re: Cochlear / Oticon Medical – attention Marisa Kuhlewein / Andy Gallagher”.

Following the closing date, queries regarding the ACCC’s review may be addressed to Marisa Kuhlewein / Andy Gallagher at mergers@accc.gov.au

For more details, please refer to the attached market inquires letter.

Market inquiries

Timeline

DateEvent
04/08/2022ACCC commenced informal review under the Informal Merger Review Process Guidelines.
23/08/2022Closing date for submissions.
27/10/2022Provisional date for announcement of ACCC’s findings (as outlined in the Informal Merger Review Process Guidelines, this may be a final decision or release of a Statement of Issues).

Project staff

  • Marisa Kuhlewein
  • Andy Gallagher

Contact email